⌘K

16:01:00·46d

PRReleasevia Quantisnow

Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

ByQuantisnow·Wall Street's wire, on your screen.

SKYE· Skye Bioscience Inc.

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

SKYE
Skye Bioscience Inc.
Health Care

Recent analyst ratings

Oct 6UpdateCraig Hallum$2.00
Oct 6UpdateCantor Fitzgerald$2.00
Aug 15UpdateEvercore ISI$10.00
Feb 28UpdateWilliam Blair-
Sep 30UpdateScotiabank$20.00
Sep 10UpdateJMP Securities$15.00

Related

SEC9d
SEC Form DEFA14A filed by Skye Bioscience Inc.
SEC9d
SEC Form DEF 14A filed by Skye Bioscience Inc.
PR18d
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
SEC19d
SEC Form PRE 14A filed by Skye Bioscience Inc.
SEC19d
SEC Form PREM14A filed by Skye Bioscience Inc.
SEC19d
Amendment: SEC Form 8-K/A filed by Skye Bioscience Inc.
SEC22d
Skye Bioscience Inc. filed SEC Form 8-K: Financial Statements and Exhibits
INSIDER23d
SEC Form 4 filed by Smith Karen L.